Chronic Rhinosinusitis (Diagnosis) Clinical Trials

9 recruiting

Chronic Rhinosinusitis (Diagnosis) Trials at a Glance

9 actively recruiting trials for chronic rhinosinusitis (diagnosis) are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Early Phase 1 with 2 trials, with the heaviest enrollment activity in Aurora, Vienna, and Birmingham. Lead sponsors running chronic rhinosinusitis (diagnosis) studies include University of California, Los Angeles, Medical University of Vienna, and Johns Hopkins University.

Browse chronic rhinosinusitis (diagnosis) trials by phase

Treatments under study

About Chronic Rhinosinusitis (Diagnosis) Clinical Trials

Looking for clinical trials for Chronic Rhinosinusitis (Diagnosis)? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Chronic Rhinosinusitis (Diagnosis) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Chronic Rhinosinusitis (Diagnosis) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Early Phase 1

Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis

Chronic Rhinosinusitis (Diagnosis)
University of Alabama at Birmingham20 enrolled1 locationNCT03439865
Recruiting

Impact of Sinus Surgery on Individuals With Cystic Fibrosis

Cystic FibrosisChronic Rhinosinusitis (Diagnosis)
University of California, Los Angeles170 enrolled9 locationsNCT04469439
Recruiting
Early Phase 1

The Role of IL5 in Epithelial Cell Integrity

Chronic Rhinosinusitis With Nasal PolypsChronic Rhinosinusitis (Diagnosis)
Johns Hopkins University8 enrolled2 locationsNCT05895929
Recruiting
Phase 2

Topical Probiotic Sinus Irrigations for Treating Chronic Sinusitis

Chronic Rhinosinusitis (Diagnosis)
University of Illinois at Chicago60 enrolled1 locationNCT05427695
Recruiting

Sinus Disease in Young Children With Cystic Fibrosis

Cystic FibrosisChronic Rhinosinusitis (Diagnosis)Olfactory Impairment+2 more
University of California, Los Angeles80 enrolled6 locationsNCT06191640
Recruiting
Not Applicable

Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps

AsthmaChronic Rhinosinusitis With Nasal PolypsChronic Rhinosinusitis (Diagnosis)+1 more
Medical University of Vienna30 enrolled1 locationNCT05009758
Recruiting

Real-Life Chronic Rhinosinusitis Outcome Registry

Chronic Rhinosinusitis (Diagnosis)
Change Accelerator in Respiratory Care4,550 enrolled13 locationsNCT04670172
Recruiting
Phase 2

The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)

Chronic Rhinosinusitis (Diagnosis)
Oticara Australia PTY LTD24 enrolled4 locationsNCT05882903
Recruiting

The Nasal Microbiome and Its Importance in Disease

COVID-19Chronic Rhinosinusitis (Diagnosis)Anosmia
University of Aarhus619 enrolled1 locationNCT05061329